27 related articles for article (PubMed ID: 6805233)
1. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
[No Abstract] [Full Text] [Related]
2. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
Jacobson RR; Trautman JR
Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
[No Abstract] [Full Text] [Related]
3. Bacteriological status (point prevalence) of lepromatous outpatients under sulfone treatment.
Quagliato R; Bechelli LM; Almeida JO; Araujo Arantes MA
Bull World Health Organ; 1975; 52(1):57-62. PubMed ID: 764995
[TBL] [Abstract][Full Text] [Related]
4. Clinical stages in sulfone treatment of leprosy.
Rodriguez JN
Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411
[No Abstract] [Full Text] [Related]
5. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750
[No Abstract] [Full Text] [Related]
6. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
[No Abstract] [Full Text] [Related]
7. Recent advances in leprosy.
Pettit JH
Australas J Dermatol; 1968 Dec; 9(4):285-93. PubMed ID: 4886556
[No Abstract] [Full Text] [Related]
8. Progress in the chemotherapy of leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
[No Abstract] [Full Text] [Related]
9. [Leprosy research].
Luger A
Wien Klin Wochenschr; 1971 Mar; 83(10):161-5. PubMed ID: 4327066
[No Abstract] [Full Text] [Related]
10. Classification of leprosy into multibacillary and paucibacillary groups: an analysis.
Parkash O
FEMS Immunol Med Microbiol; 2009 Jan; 55(1):1-5. PubMed ID: 19040664
[TBL] [Abstract][Full Text] [Related]
11. [Disabilities observed in new cases of leprosy diagnosed in the Bamako district (Mali) in 1994].
Sow SO; Tiendrebeogo A; Hamed Oould B; Lienhart C; Ponnighaus JM
Acta Leprol; 1999; 11(4):161-70. PubMed ID: 10987047
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
